2:36
CEO Richard Saynor presents full-year results 2025
Sandoz announced its full-year financial results for 2025, with strong year-on-year net sales growth of 5% at constant currencies and an...
Načítám výsledky…
Sandoz announced its full-year financial results for 2025, with strong year-on-year net sales growth of 5% at constant currencies and an...
SANDOZ is a global leader in generic pharmaceuticals and biosimilars. It's a division of the Novartis Group. SANDOZ contributes to society's...
SAS recognizes its 2026 CEO Award of Excellence winners through a video montage showcasing their diverse backgrounds and personal interests. The...
Europe made a strong contribution to Sandoz H1 results and has much to be proud of. We have achieved 21 consecutive quarters of growth and...
This video profiles Phil Carey, the co-founder of the pharmaceutical company Sandoz, as part of the "Generations of Impact" series. He discusses...
Sandoz CEO: Europe must unite to protect local drug makers. Richard Saynor, CEO of pharmaceuticals business, Sandoz, discusses the company's...
Antibiotics, particularly penicillins, are the backbone of modern medicine. They have transformed healthcare by treating life threatening...
Pioneering access is a team effort That's why we welcomed nearly 50 supplier partners to Basel for the 2025 Sandoz Supplier Summit — a...
A night to celebrate impact From inspiring stories to powerful moments of recognition — the Sandoz CEO Awards brought colleagues together in...
In his video, our CEO Richard Saynor shares how Sandoz plans to unlock its full potential through ambitious growth plans driven by a...